Screener
Haemonetics HAE Invested capital
Discontinued — last reported Q1 '27
Invested capital at other companies
Other financials
Where this comes from
Calculated from Haemonetics’s reported figures.
The source filing: Haemonetics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 6:09 AM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0000313143-26-000120
FAQ
- What is Haemonetics's invested capital?
- Haemonetics (HAE) reported invested capital of $1.79B in Q2 2026.
- How has Haemonetics's invested capital changed year-over-year?
- Haemonetics's invested capital decreased by 1.5% year-over-year, from $1.81B to $1.79B.
- What is the long-term trend for Haemonetics's invested capital?
- Over 5 years (2021 to 2026), Haemonetics's invested capital has grown at a 6.7% compound annual growth rate (CAGR), from $1.32B to $1.83B.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Haemonetics's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude